Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Hashimoto

Showing results (291-300 of 319) with videos related to

Pageof 32
Sort By:
Pharmacology Research & Perspectives|December 16, 2014
Involvement of S1P1 receptor pathway in angiogenic effects of a novel adenosine-like nucleic acid analog COA-Cl in cultured human vascular endothelial cellsJunsuke Igarashi, Takeshi Hashimoto, Yasuo Kubota, et al.
The Journal of Biological Chemistry|April 26, 2012
Perilipin 5, a lipid droplet-binding protein, protects heart from oxidative burden by sequestering fatty acid from excessive oxidationKenta Kuramoto, Tomoo Okamura, Tomohiro Yamaguchi, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2024
Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in JapanYosuke Hirasawa, Takahiro Adachi, Takeshi Hashimoto, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 29, 2021
Inhibition of HIPK2 Alleviates Thoracic Aortic Disease in Mice With Progressively Severe Marfan SyndromeCristina I Caescu, Jens Hansen, Brittany Crockett, et al.
World Journal of Urology|February 18, 2020
Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohortTomohisa Matsunaga, Kazumasa Komura, Takeshi Hashimoto, et al.
BMC Cancer|February 28, 2021
Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy ~ data from a multi-institutional study in Japan ~Takeshi Tsutsumi, Kazumasa Komura, Takeshi Hashimoto, et al.
Anticancer Research|August 1, 2025
Rash and Endocrine Disorders Predict Improved Survival in Metastatic Renal Cell Carcinoma Treated With ImmunotherapyKoichi Sugimoto, Takafumi Minami, Shingo Toyoda, et al.
Annals of Surgical Oncology|June 27, 2019
The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in JapanKazumasa Komura, Takeshi Hashimoto, Takuya Tsujino, et al.
Japanese Journal of Clinical Oncology|August 23, 2024
Clinical outcomes and prognostic factors in metastatic nonclear cell renal cell carcinoma treated with immuno-oncology combination therapyShingo Toyoda, Wataru Fukuokaya, Keiichiro Mori, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 14, 2019
Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancerToshikazu Takeda, Amy L Tin, Renato B Corradi, et al.
Pageof 32

Showing results (291-300 of 319) with videos related to

Sort By:
Pageof 32
Pharmacology Research & Perspectives|December 16, 2014
Involvement of S1P1 receptor pathway in angiogenic effects of a novel adenosine-like nucleic acid analog COA-Cl in cultured human vascular endothelial cellsJunsuke Igarashi, Takeshi Hashimoto, Yasuo Kubota, et al.
The Journal of Biological Chemistry|April 26, 2012
Perilipin 5, a lipid droplet-binding protein, protects heart from oxidative burden by sequestering fatty acid from excessive oxidationKenta Kuramoto, Tomoo Okamura, Tomohiro Yamaguchi, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2024
Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in JapanYosuke Hirasawa, Takahiro Adachi, Takeshi Hashimoto, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 29, 2021
Inhibition of HIPK2 Alleviates Thoracic Aortic Disease in Mice With Progressively Severe Marfan SyndromeCristina I Caescu, Jens Hansen, Brittany Crockett, et al.
World Journal of Urology|February 18, 2020
Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohortTomohisa Matsunaga, Kazumasa Komura, Takeshi Hashimoto, et al.
BMC Cancer|February 28, 2021
Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy ~ data from a multi-institutional study in Japan ~Takeshi Tsutsumi, Kazumasa Komura, Takeshi Hashimoto, et al.
Anticancer Research|August 1, 2025
Rash and Endocrine Disorders Predict Improved Survival in Metastatic Renal Cell Carcinoma Treated With ImmunotherapyKoichi Sugimoto, Takafumi Minami, Shingo Toyoda, et al.
Annals of Surgical Oncology|June 27, 2019
The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in JapanKazumasa Komura, Takeshi Hashimoto, Takuya Tsujino, et al.
Japanese Journal of Clinical Oncology|August 23, 2024
Clinical outcomes and prognostic factors in metastatic nonclear cell renal cell carcinoma treated with immuno-oncology combination therapyShingo Toyoda, Wataru Fukuokaya, Keiichiro Mori, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 14, 2019
Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancerToshikazu Takeda, Amy L Tin, Renato B Corradi, et al.
Pageof 32